Walleye Trading’s Inhibrx, Inc. Common Stock INBX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-11,214
Closed -$212K 5514
2023
Q1
$212K Buy
11,214
+1,168
+12% +$27.2K ﹤0.01% 3467
2022
Q4
$248K Sell
10,046
-2,934
-23% -$86.2K ﹤0.01% 3408
2022
Q3
$233K Buy
+12,980
New +$234K ﹤0.01% 3557

Other funds holding INBX

Walleye Trading's INBX Position: Q2 2023 in Review

Walleye Trading sold out of Inhibrx, Inc. Common Stock (INBX) in Q2 2023, closing a stake of 11,214 shares — an estimated $212K sold.

Walleye Trading first reported a position in INBX in Q3 2022 and held it in 3 quarters. The position peaked at $248K in Q4 2022. 107 funds tracked by Wall St. Rank hold INBX as of Q2 2023.

  • Walleye Trading reported no remaining Inhibrx, Inc. Common Stock position as of Q2 2023 after selling out during the quarter.
  • Walleye Trading sold 11,214 Inhibrx, Inc. Common Stock shares in Q2 2023, an estimated $212K.
  • Walleye Trading first reported a position in Inhibrx, Inc. Common Stock in Q3 2022 and held it in 3 quarters.
  • Walleye Trading's Inhibrx, Inc. Common Stock position peaked at $248K in Q4 2022.
  • 107 funds tracked by Wall St. Rank held Inhibrx, Inc. Common Stock as of Q2 2023.

Based on Walleye Trading's 13F filing for Q2 2023, filed 14 Aug 2023.